GGrantIndex
Sort

16,300 grants matching fatty liver disease

Genetic and Environmental risk of NAFLD-related HCC In All Latinos: the GENIAL Study

$329,649
Patricia Denise Jones · University Of Miami School Of Medicine · U01 · FY2024 · CA

FIBRONECTION IN HEPATIC ISCHEMIA REPERFUSION INJURY

$329,612
Ana J. Coito · University Of California Los Angeles · R01 · FY2007 · AI

Protein-Releasing Microporous Scaffolds for Cell Replacement Therapy

$329,565
Lonnie D Shea · Northwestern University · R01 · FY2010 · EB

Regulation of a Novel Intestinal NHE Isoform (NHE8)

$329,513
Fayez Khalaf Ghishan · University Of Arizona · R01 · FY2014 · DK

Regulation of a Novel Intestinal NHE Isoform (NHE8)

$329,513
Fayez Khalaf Ghishan · University Of Arizona · R01 · FY2011 · DK

Regulation of a Novel Intestinal NHE Isoform (NHE8)

$329,513
Fayez Khalaf Ghishan · University Of Arizona · R01 · FY2012 · DK

Regulation of a Novel Intestinal NHE Isoform (NHE8)

$329,513
Fayez Khalaf Ghishan · University Of Arizona · R01 · FY2015 · DK

Mechanism of cholesterol regulation by the mitochondrial translocator protein (TSPO)

$329,422
Vimal Selvaraj · Cornell University · R01 · FY2018 · DK

Inhibitors of Maf1-dependent transcriptional repression

$329,391
Ian M Willis · Albert Einstein College Of Medicine, Inc · R01 · FY2016 · GM

The Role of Leptin in Liver Fibrogenesis

$329,375
Frank A. Anania · Emory University · R01 · FY2009 · DK

Genetics of Type 2 Diabetes

$329,287
Steven C Elbein · Univ Of Arkansas For Med Scis · R01 · FY2008 · DK

Targeting Lipid Metabolism in Colorectal Cancer

$329,272
Yekaterina Zaytseva · University Of Kentucky · R01 · FY2024 · CA

Diabetes Prevention Phenotyping Core

$329,267
Philip A Kern · University Of Kentucky · P20 · FY2025 · GM

Project 1 - Disruption of CpG island-mediated gene regulation and chromatin architecture in progeria and aging

$329,173
Samuel Beck · Mount Desert Island Biological Lab · P20 · FY2020 · GM

Gain of function mutations in inflammasome related genes in human and experimental alcoholic liver disease

$329,168
Ariel Feldstein · University Of California, San Diego · R01 · FY2019 · AA

Gain of function mutations in inflammasome related genes in human and experimental alcoholic liver disease

$329,168
Ariel Feldstein · University Of California, San Diego · R01 · FY2021 · AA

Gain of function mutations in inflammasome related genes in human and experimental alcoholic liver disease

$329,168
Ariel Feldstein · University Of California, San Diego · U01 · FY2018 · AA

Gain of function mutations in inflammasome related genes in human and experimental alcoholic liver disease

$329,168
Ariel Feldstein · University Of California, San Diego · R01 · FY2020 · AA

Bariatric Surgery for Morbid Obesity: Clinical and Pathophysiologic Consequences

$329,153
Paul David Berk · Columbia University Health Sciences · R01 · FY2010 · DK

FACILITATED UPTAKE OF LONG CHAIN FATTY ACIDS IN OBESITY

$329,129
Paul David Berk · Columbia University Health Sciences · R01 · FY2008 · DK

Project 3: A Novel Simultaneous Multiparametric MRI Approach for the Quantitative Assessment of Non-alcoholic Fatty Liver Disease

$329,124
Christoph Alexander Rettenmeier · University Of Hawaii At Manoa · P20 · FY2023 · GM

Advancing Broad Spectrum Host-Targeting Antiviral Strategies to the Clinic

$329,066
Jeffrey S Glenn · Stanford University · U19 · FY2019 · AI

Fetal Postnatal Regulation of Expression of the GH Receptor

$329,062
Ram K. Menon · University Of Michigan At Ann Arbor · R01 · FY2007 · DK

Manipulation of STAT3 Signaling for Muscle Preservation in Cancer Cachexia

$329,025
Teresa A Zimmers · Thomas Jefferson University · R01 · FY2012 · CA

Food FARMacia: Reducing Childhood Obesity in Households with Food Insecurity

$329,000
Jennifer Aimee Woo Baidal · Columbia University Health Sciences · R01 · FY2023 · DK